Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

LMAT

LeMaitre

NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.78

-0.60

-1.17%

After Hours: 50.78 0 0.00% 16:01 03/03 EST

OPEN

51.91

PREV CLOSE

51.38

HIGH

52.55

LOW

50.26

VOLUME

210.18K

TURNOVER

52 WEEK HIGH

54.96

52 WEEK LOW

18.76

MARKET CAP

1.03B

P/E (TTM)

55.24

News

Financial

Releases

Corp Actions

Analysis

Profile

Be Sure To Check Out LeMaitre Vascular, Inc. (NASDAQ:LMAT) Before It Goes Ex-Dividend

LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) is about to trade ex-dividend in the next four days. You can purchase shares...

Simply Wall St. · 19h ago

Neurovascular Embolectomy Device Market Share, Size, Growth, 2021 Industry Trends, Global Business Prospects, Forthcoming Developments, Analysis, Research, Impact of COVID-19 on Business and Forecast to 2025

Mar 02, 2021 (The Expresswire) -- Global "Neurovascular Embolectomy Device Market" (2021) thoroughly scrutinizes the effects of a wide range of factors...

The Express Wire · 1d ago

Neurovascular Embolectomy Device Market Size, Share | Global Companies, Consumption, Drivers, Growth Status, Top Leading Countries, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2027

Mar 02, 2021 (The Expresswire) -- Global Neurovascular Embolectomy Device Market Research Report offers in-depth analysis on Market size, share, drivers,...

The Express Wire · 1d ago

Uptrend Call Working As Lemaitre Vascula Stock Rises 34.5% (LMAT)

Mar 01, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Lemaitre Vascula (NASDAQ:LMAT) on December 22nd, 2020 at $38.04. In...

marketwatch.com · 2d ago

DJ LeMaitre Vascular's CEO George LeMaitre on Q4 2020 Results -- Earnings Call Transcript >LMAT

Dow Jones · 3d ago

--Analyst Actions: Barrington Adjusts LeMaitre Vascular PT to $49 From $47, Maintains Outperform Rating

MT Newswires · 5d ago

LeMaitre Vascular Q4 EPS $0.34 Beats $0.29 Estimate, Sales $37.55M Beat $35.58M Estimate

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.29 by 17.24 percent. This is a 47.83 percent increase over earnings of $0.23 per share from

Benzinga · 6d ago

LeMaitre Vascular hikes quarterly dividend by ~16%

LeMaitre Vascular (LMAT) declares $0.11/share quarterly dividend, 15.8% increase from prior dividend of $0.10.Forward yield 0.94%Payable March 25; for shareholders of record March 9; ex-div March 8.See LMAT Dividend Scorecard,

Seekingalpha · 6d ago

Forecast

EPSBVPSCFPS

Actual (USD)

Estimate (USD)

Income StatementMore

Net IncomeTotal RevenueOperating Income

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

OperatingInvestingFinancing

Operating (USD)

YoY (%)

Learn about the latest financial forecast of LMAT. Analyze the recent business situations of LeMaitre through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LMAT stock price target is 54.00 with a high estimate of 65.00 and a low estimate of 48.00.

EPS

Institutional Holdings

Institutions: 247

Institutional Holdings: 19.15M

% Owned: 94.12%

Shares Outstanding: 20.34M

TypeInstitutionsShares

Increased

1.30M

New

152.18K

Decreased

908.00K

Sold Out

Performance
Asset Allocation
Dividend History

No Data

Industry

Advanced Medical Equipment & Technology

-2.96%

Healthcare Equipment & Supplies

-2.63%

Key Executives

President/Director

David Roberts

Chief Financial Officer/Director

Joseph Pellegrino

Senior Vice President/General Counsel

Laurie Churchill

Senior Vice President

Andrew Hodgkinson

Senior Vice President

Trent Kamke

Vice President - Operations

Stephane Maier

Vice President/Director of Sales

Giovannella Deiure

Vice President/Director of Sales

Chance Kriesel

Vice President/Director of Marketing

Kimberly Cieslak

Vice President

Roli Kumar-Choudhury

Vice President

Jonathan Ngau

Vice President

Jacob Petersen

Vice President

Xiang Zhang

Vice President - Research & Development

Ryan Connelly

Director of Sales

Helen Goulding

Other

James Russell

Independent Director

Lawrence Jasinski

Independent Director

John O'Connor

Independent Director

Bridget Ross

Independent Director

John Roush

Dividends
Splits
Insider Activity

Declaration Date Dividend Per Share Ex-Div Date: 02/23/2021
Dividend USD 0.11
03/08/2021; 10/20/2020
Dividend USD 0.095
11/18/2020; 07/21/2020
Dividend USD 0.095
08/26/2020; 04/28/2020
Dividend USD 0.095
05/19/2020; 01/30/2020
Dividend USD 0.095
03/02/2020; 10/21/2019
Dividend USD 0.085
11/19/2019; 07/22/2019
Dividend USD 0.085
08/20/2019; 04/29/2019
Dividend USD 0.085
05/21/2019; 02/14/2019
Dividend USD 0.085
03/21/2019; 10/04/2018
Dividend USD 0.07
11/19/2018; 07/23/2018
Dividend USD 0.07
08/21/2018; 04/23/2018
Dividend USD 0.07
05/21/2018; 02/15/2018
Dividend USD 0.07
03/21/2018; 10/24/2017
Dividend USD 0.055
11/21/2017; 07/25/2017
Dividend USD 0.055
08/21/2017; 04/24/2017
Dividend USD 0.055
05/22/2017; 02/16/2017
Dividend USD 0.055
03/20/2017; 10/24/2016
Dividend USD 0.045
11/17/2016; 07/25/2016
Dividend USD 0.045
08/18/2016; 04/25/2016
Dividend USD 0.045
05/23/2016; 02/22/2016
Dividend USD 0.045
03/17/2016; 10/22/2015
Dividend USD 0.04
11/18/2015; 07/23/2015
Dividend USD 0.04
08/18/2015; 04/23/2015
Dividend USD 0.04
05/20/2015; 02/23/2015
Dividend USD 0.04
03/18/2015; 10/23/2014
Dividend USD 0.035
11/18/2014; 07/24/2014
Dividend USD 0.035
08/19/2014; 04/24/2014
Dividend USD 0.035
05/20/2014; 02/20/2014
Dividend USD 0.035
03/18/2014; 10/23/2013
Dividend USD 0.03
11/18/2013; 07/24/2013
Dividend USD 0.03
08/19/2013; 04/24/2013
Dividend USD 0.03
05/20/2013; 02/21/2013
Dividend USD 0.03
03/18/2013; 10/30/2012
Dividend USD 0.025
11/16/2012; 07/25/2012
Dividend USD 0.025
08/15/2012; 04/25/2012
Dividend USD 0.025
05/16/2012; 02/23/2012
Dividend USD 0.025
03/16/2012; 10/25/2011
Dividend USD 0.02
11/21/2011; 07/26/2011
Dividend USD 0.02
08/17/2011; 04/26/2011
Dividend USD 0.02
05/18/2011; 02/24/2011
Dividend USD 0.02
03/18/2011

All
Financials
Insiders

About LMAT

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMAT stock methods without spending real money on the virtual paper trading platform.